Group One Trading
PHAT icon

Group One Trading’s Phathom Pharmaceuticals PHAT Stock Holding History

Group One Trading’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,500
Closed -$17.7K – 8915
2025
Q3 		$17.7K Sell
1,500
-24,600
-94% -$254K ﹤0.01% 6796
2025
Q2 		$250K Buy
26,100
+15,700
+151% +$86.9K ﹤0.01% 4113
2025
Q1 		$65.2K Buy
10,400
+9,800
+1,633% +$59.5K ﹤0.01% 4941
2024
Q4 		$4.87K Sell
600
-23,100
-97% -$286K ﹤0.01% 6421
2024
Q3 		$428K Hold
23,700
– – ﹤0.01% 2972
2024
Q2 		$244K Sell
23,700
-2,400
-9% -$24.7K ﹤0.01% 3233
2024
Q1 		$277K Buy
26,100
+25,000
+2,273% +$212K ﹤0.01% 3281
2023
Q4 		$10K Buy
1,100
+900
+450% +$7.75K ﹤0.01% 6198
2023
Q3 		$2.07K Sell
200
-1,200
-86% -$16.5K ﹤0.01% 7024
2023
Q2 		$20K Buy
+1,400
New +$16.1K ﹤0.01% 5996

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return